The BioCentury Show
合計時間：
21 h 56 min
Ep. 98 - Inside Precision Oncology’s Next Chapter with Fore’s Bill Hinshaw
The BioCentury Show
37:38
Popular Episode - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
The BioCentury Show
38:39
Ep. 97 – From NIH to Industry: Zerhouni Warns Policy & Rhetoric Threaten U.S. Science
The BioCentury Show
34:11
Ep. 96 – From Pharma Partnering to Biotech CEO: Sophie Kornowski on Boston Pharma’s Playbook
The BioCentury Show
32:17
Ep. 95 - Kymera CEO Nello Mainolfi: Matching Degrader Chemistry to the Problem
The BioCentury Show
31:33
Ep. 94 - Frazier's James Li on China’s Rapidly Evolving Biotech Deal Landscape
The BioCentury Show
29:45
Ep. 93 – BIO’s Fritz Bittenbender on Trump 2.0, MFN Threats & Pharma’s Concessions
The BioCentury Show
34:03
Ep. 92 - Reimagining FDA: Steve Usdin on Designing the Drug Regulator of the Future
The BioCentury Show
38:43
Ep. 91 – Annalisa Jenkins: How MHRA’s Reset Could Revive U.K. Biotech
The BioCentury Show
36:07
Popular Episode - Vertex’s Winning Formula: Altshuler on Choosing the Next Breakthroughs
The BioCentury Show
32:44
Ep. 90 – Inside Biopharma Dealmaking: ProFound CEO John Lepore on Knowing What Partners Want
The BioCentury Show
33:05
Ep. 89 - Delivering on the biosimilars promise, a conversation with Gillian Woollett
The BioCentury Show
31:47
Ep. 88 – From Satiety to Muscle: Zealand CEO Steensberg on Amylin’s Edge in Obesity
The BioCentury Show
30:41
Ep. 87 – Korea’s Biotech Playbook: Orum CEO SJ Lee on Going Global and Creating Novel Therapies
The BioCentury Show
27:41
Ep. 86 – Macrophages, ASCO & Clever-1: Faron CEO Juho Jalkanen on Bexmarilimab’s Promise
The BioCentury Show
10:22
Ep. 85 - Stifel’s Opler on Trump 2.0's FDA & the Capital Markets
The BioCentury Show
32:39
Ep. 84 – Leadership Amid Turmoil: Moonlake CEO Jorge Santos Da Silva
The BioCentury Show
29:19
Ep. 83 – Europe’s Biotech Moment: Jérôme van Biervliet on Turning Uncertainty into Opportunity
The BioCentury Show
31:54
Ep. 82 – Act Now or Fall Behind: Michelle Rozo on Biotech’s National Security Stakes
The BioCentury Show
31:01
Ep. 81 - Data-Driven Growth: Immunocore CEO Bahija Jallal on Expanding TCR Therapies
The BioCentury Show
30:52
Ep. 80 - Vertex’s Winning Formula: Altshuler on Choosing the Next Breakthroughs
The BioCentury Show
32:26
Ep. 79 - BNP Paribas’ Moneer on Biotech’s Bull Case: M&A, PE, and Market Recovery
The BioCentury Show
29:33
Ep. 78 - Biotech’s New Normal: SR One’s Simeon George on Adapting to Market Constraints
The BioCentury Show
31:04
Ep. 77 - AI’s Next Leap: Foresite Labs’ Vik Bajaj on Predictive Biology
The BioCentury Show
35:29
Ep. 76 - FDA Inflection Point: Steve Usdin on Biopharma during Trump 2.0
The BioCentury Show
34:01
Ep. 75 - PBMs, IRA, RFK Jr: A Conversation With Rep. Jake Auchincloss
The BioCentury Show
36:04
Ep. 74 - Chris Bardon on Biotech’s Recovery: Valuations, Obesity Drugs, and M&A
The BioCentury Show
34:03
Ep. 73 - Resilience and the CEO’s Paradox: Aoife Brennan on Leading in Biotech
The BioCentury Show
32:12
Ep. 72 - Outlook for Biotech M&A and Financing: Sidley's Robert Darwin
The BioCentury Show
35:54
Ep. 71 - Pazdur Unplugged: FDA Director Richard Pazdur on the Past, Future of Cancer Treatments
The BioCentury Show
41:44
Ep. 70 - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
The BioCentury Show
33:56
Ep. 69 - Lee Fleisher: An Insider’s Account of CMS’s Alzheimer’s Coverage Decisions
The BioCentury Show
34:36
Ep. 68 - Inside BeiGene: CEO John Oyler on Owning the Drug Development Process
The BioCentury Show
35:08
Ep 67 - AAM's Craig Burton on Opportunities, Challenges of U.S. Biosimilars Market
The BioCentury Show
28:51
Popular Episode - Bob Nelsen on AI, China and the IRA
The BioCentury Show
35:33
Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine
The BioCentury Show
32:23
Ep. 65 - Astellas' Claus Zieler: Global Launches with Local Impact
The BioCentury Show
32:27
Ep. 64 - NPC CEO John O’Brien: Why America Needs an Honest Conversation About Drug Pricing
The BioCentury Show
33:36
Ep. 63 - Day One's Jeremy Bender: Building Pediatric Oncology from the Ground Up
The BioCentury Show
32:27
Ep. 62 - Rick Bright: Navigating the Avian Flu Threat
The BioCentury Show
40:22
